BNP Paribas Financial Markets’s Celularity CELU Stock Holding History

BNP Paribas Financial Markets’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59	Hold	99	–	–	﹤0.01%	5819
2026 Q1	$132	Hold	99	–	–	﹤0.01%	5657
2025 Q4	$110	Hold	99	–	–	﹤0.01%	5605
2025 Q3	$205	Sell	99 -20	-17%	-$56	﹤0.01%	5391
2025 Q2	$233	Sell	119 -10	-8%	-$18	﹤0.01%	5275
2025 Q1	$223	Sell	129 -9	-7%	-$17	﹤0.01%	5200
2024 Q4	$287	Sell	138 -19	-12%	-$45	﹤0.01%	5214
2024 Q3	$466	Hold	157	–	–	﹤0.01%	4008
2024 Q2	$491	Sell	157 -44	-22%	-$153	﹤0.01%	3906
2024 Q1	$1.05K	Buy	+201	New	+$826	﹤0.01%	3858
2022 Q4	–	Sell	-2,166	Closed	-$50K	–	4144
2022 Q3	$50K	Buy	+2,166	New	+$65.7K	﹤0.01%	3980

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

KFS

Keynote Financial Services Vernon, Connecticut $214M AUM 60.12% 1-Year Est. Return

BNP Paribas Financial Markets's CELU Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Celularity (CELU) position steady in Q2 2026 at 99 shares worth $59. The position accounts for ﹤0.01% of the portfolio, ranked #5819.

BNP Paribas Financial Markets first reported a position in CELU in Q3 2022 and has held it in 11 quarters since. The position peaked at $50K in Q3 2022. 33 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

BNP Paribas Financial Markets held 99 shares of Celularity worth $59 as of Q2 2026.
BNP Paribas Financial Markets left its Celularity share count unchanged in Q2 2026.
Celularity made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5819 holding.
BNP Paribas Financial Markets first reported a position in Celularity in Q3 2022 and has held it in 11 quarters since.
BNP Paribas Financial Markets's Celularity position peaked at $50K in Q3 2022.
33 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.